|
|
|
|
|
Teisinis statusas
Patentas galioja
| (51) | INT.CL. | A61K 31/422 | (2006.01) |
| A61K 31/4245 | (2006.01) | ||
| A61K 31/433 | (2006.01) | ||
| C07D 285/08 | (2006.01) | ||
| C07D 285/135 | (2006.01) | ||
| C07D 213/73 | (2006.01) | ||
| C07D 237/20 | (2006.01) | ||
| C07D 239/42 | (2006.01) | ||
| C07D 241/20 | (2006.01) | ||
| C07D 263/48 | (2006.01) | ||
| C07D 277/40 | (2006.01) | ||
| C07D 401/12 | (2006.01) | ||
| C07D 417/12 | (2006.01) | ||
| C07D 271/07 | (2006.01) | ||
| C07D 271/113 | (2006.01) | ||
| C07D 253/07 | (2006.01) | ||
| C07D 261/14 | (2006.01) | ||
| C07D 285/12 | (2006.01) | ||
| C07D 413/12 | (2006.01) |
| (11) | Patento numeris | 2598482 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11749119.1 |
| Europos patento paraiškos padavimo data | 2011-07-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-06-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-04 |
| (46) | Apibrėžties vertimo paskelbimo data | 2018-07-10 |
| (86) | Numeris | PCT/EP2011/062949 |
| Data | 2011-07-27 |
| (87) | Numeris | WO 2012/013728 |
| Data | 2012-02-02 |
| (30) | Numeris | Data | Šalis |
| 11160738 | 2011-03-31 | EP | |
| 11160731 | 2011-03-31 | EP | |
| 11160728 | 2011-03-31 | EP | |
| 10171342 | 2010-07-29 | EP |
| (72) |
ORTEGA MUŃOZ, Alberto, ES
FYFE, Matthew, Colin, Thor, ES
MARTINELL PEDEMONTE, Marc, ES
TIRAPU FERNANDEZ DE LA CUESTA, Ińigo, ES
ESTIARTE-MARTINEZ, Maria de los Angeles, ES
|
| (73) |
Oryzon Genomics, S.A.,
Carrera de San Jer nimo 15, 2nd Floor, 28014 Madrid,
ES
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Demetilazės LSD1 inhibitoriai arilciklopropilamino pagrindu ir jų medicininis panaudojimas |
| ARYLCYCLOPROPYLAMINE BASED DEMETHYLASE INHIBITORS OF LSD1 AND THEIR MEDICAL USE |
| Mokėjimo data | Galiojimo metai | Suma | |
| 2025-07-22 | 15 | 289.00 EUR |
| 2026-07-27 |